CoreCap Advisors’s CalciMedica CALC Stock Holding History

CoreCap Advisors’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-45	Closed	-$159	–	3162
2024 Q4	$159	Buy	+45	New	+$158	﹤0.01%	2743

Other funds holding CALC

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

WIA

Wealthedge Investment Advisors New York $272M AUM 10.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

MPM

Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

CoreCap Advisors's CALC Position: Q1 2025 in Review

CoreCap Advisors sold out of CalciMedica (CALC) in Q1 2025, closing a stake of 45 shares — an estimated $159 sold.

CoreCap Advisors first reported a position in CALC in Q4 2024 and held it in 1 quarter. The position peaked at $159 in Q4 2024. 30 funds tracked by Wall St. Rank hold CALC as of Q1 2025.

CoreCap Advisors reported no remaining CalciMedica position as of Q1 2025 after selling out during the quarter.
CoreCap Advisors sold 45 CalciMedica shares in Q1 2025, an estimated $159.
CoreCap Advisors first reported a position in CalciMedica in Q4 2024 and held it in 1 quarter.
CoreCap Advisors's CalciMedica position peaked at $159 in Q4 2024.
30 funds tracked by Wall St. Rank held CalciMedica as of Q1 2025.

Based on CoreCap Advisors's 13F filing for Q1 2025, filed 9 May 2025.